Outpatient Management of Pulmonary Embolism Patients with Direct Oral Anticoagulants: A Systematic Review
Journal of Clinical Medicine · 17.12.2025 · 14 (24) · 8931
DOI: 10.3390/jcm14248931 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 17.12.2025. Verfasst von Alvina S Khachatryan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Fundamental and Applied Research in Cardiovascular Surgery, Pirogov Russian National Research Medical University, Moscow 117997, Russia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pulmonary embolism (PE) patients are generally admitted to the hospital, which leads to significant burden on healthcare systems. Many PE patients are hemodynamically stable and can be ambulated safely. Direct oral anticoagulants (DOACs) do not need routine laboratory monitoring, which makes them a convenient option for outpatient care. Data on the outpatient management of PE patients using DOACs are scarce.
Methods
We conducted a systematic search of MECENTRAL databases to identify randomized controlled trials (RCTs), non-randomized studies (non-RCTs), retrospective studies, reviews, systematic reviews, meta-analyses, and clinical guidelines evaluating the use of DOACs for outpatient treatment of PE patients.
Results
A total of 833 publications were identified, and eight studies—two RCTs and six non-RCTs (two retrospective and four prospective)—were finally included. These studies reported rates of bleeding events, recurrent venous thromboembolism (VTE), PE-related mortality, and all-cause mortality among outpatients who received DOACs. No PE-related deaths were reported in any of the included studies. Bleeding events were reported in five studies, and recurrent VTE rates were reported in two studies. Study findings showed that the sPESI score has some disadvantages in selecting patients for home treatment. The quality of the studies varied considerably. A meta-analysis could not be performed due to heterogeneity in the study designs, patient populations, and outcome reporting. While the treatment results favored outpatient management of selected PE patients, no robust conclusions could be drawn from the published data.
Conclusions
Outpatient treatment of PE with DOACs has some potential as an approach for managing selected patients. Hestia, POMPE-C and RESI scores are preferable for selecting PE patients for home treatment, but utilizing sPESI as the only tool has to be avoided. Apixaban and rivaroxaban are both safe, with a low bleeding risk. Large-scale prospective studies are required to establish the efficacy and safety of outpatient PE management using DOACs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Fundamental and Applied Research in Cardiovascular Surgery, Pirogov Russian National Research Medical University, Moscow 117997, Russia.
ORCID-Profile: Alvina S Khachatryan, Denis V Rylnikov, Sevara A Mirakhmedova, Evgeny I Seliverstov, Igor A Zolotukhin
Zitieren
APA
Khachatryan, A. S., Rylnikov, D. V., Mirakhmedova, S. A., Seliverstov, E. I., An, E. S., & Zolotukhin, I. A. (2025). Outpatient Management of Pulmonary Embolism Patients with Direct Oral Anticoagulants: A Systematic Review. Journal of Clinical Medicine, 14(24), 8931. https://doi.org/10.3390/jcm14248931
Vancouver
Khachatryan AS, Rylnikov DV, Mirakhmedova SA, Seliverstov EI, An ES, Zolotukhin IA. Outpatient Management of Pulmonary Embolism Patients with Direct Oral Anticoagulants: A Systematic Review. Journal of Clinical Medicine. 2025;14(24):8931. doi:10.3390/jcm14248931
BibTeX
@article{Khachatryan2025,
author = {Khachatryan, Alvina S and Rylnikov, Denis V and Mirakhmedova, Sevara A and Seliverstov, Evgeny I and An, Evgeny S and Zolotukhin, Igor A},
title = {Outpatient Management of Pulmonary Embolism Patients with Direct Oral Anticoagulants: A Systematic Review},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {24},
pages = {8931},
doi = {10.3390/jcm14248931}
}
EUVIMED